Regeneron (REGN)

622.45 +13.28 (2.18%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/20 *Est.)

Latest Headlines

Regeneron (REGN), Sanofi (SNY) Announce Kevzara Phase 3 U.S. Trial in COVID-19 Patients Did Not Meet its Primary and Secondary Endpoints July 2, 2020 4:30 PM - StreetInsider Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients July 2, 2020 4:30 PM - StreetInsider Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients July 2, 2020 4:29 PM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: Jul 01 Filed by: BROWN MICHAEL S July 2, 2020 4:03 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jul 01 Filed by: RYAN ARTHUR F July 2, 2020 4:02 PM - SEC Filing UPDATE: Regeneron Pharma (REGN) PT Raised to $675 at Oppenheimer Due to Success of Assets, Especially Eylea July 1, 2020 8:13 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Jun 29 Filed by: Landry Robert E June 30, 2020 4:03 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jun 29 Filed by: SING GEORGE L June 29, 2020 4:09 PM - SEC Filing Regeneron (REGN) call put ratio 2.6 calls to 1 put amid rise in Covid 19 cases June 25, 2020 5:23 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Jun 22 Filed by: Landry Robert E June 24, 2020 4:04 PM - SEC Filing Regeneron (REGN) Says There is No Merit to Civil Complaint, to Vigorously Defend Allegations Related to Contributions to Patient Assistance Charity June 24, 2020 3:24 PM - StreetInsider Regeneron to Vigorously Defend Allegations Related to Contributions to a Patient Assistance Charity in 2013 and Early 2014 June 24, 2020 3:23 PM - PR NewsWire Regeneron (REGN) Announces New Publication Highlights Preclinical Research Showing Potential to Enhance Cancer Treatment by Combining Novel Costimulatory Bispecific Antibodies with Libtayo June 24, 2020 2:01 PM - StreetInsider New Publication Highlights Preclinical Research Showing Potential to Enhance Cancer Treatment by Combining Novel Costimulatory Bispecific Antibodies with Libtayo® (cemiplimab) June 24, 2020 2:00 PM - PR NewsWire DoJ files a suit versus Regeneron (REGN) alleging kickbacks for Eylea - Bloomberg June 24, 2020 12:14 PM - StreetInsider Regeneron Pharma (REGN) PT Raised to $700 at Credit Suisse June 24, 2020 6:12 AM - StreetInsider Sanofi clinches $2 billion vaccines deal with Translate Bio June 23, 2020 7:10 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Jun 19 Filed by: Bassler Bonnie L June 22, 2020 4:18 PM - SEC Filing Regeneron Announces the 2020 Winners of the Regeneron Prize for Creative Innovation June 22, 2020 7:00 AM - PR NewsWire FDA approves new Dupixent® (dupilumab) pre-filled pen designed to support more convenient self-administration June 19, 2020 1:51 PM - PR NewsWire UPDATE: Regeneron (REGN), Sanofi (SNY) Report FDA Approval of Dupixent (dupilumab) Pre-filled Pen Designed to Support More Convenient Self-Administration June 19, 2020 1:49 PM - StreetInsider FDA Approves New Dupixent® (dupilumab) Pre-filled Pen Designed to Support More Convenient Self-Administration June 19, 2020 1:44 PM - PR NewsWire Regeneron (REGN), Sanofi (SNY) announce Dupixent approved in China for adults with moderate-to-severe atopic dermatitis June 19, 2020 7:32 AM - StreetInsider Regeneron (REGN), Sanofi (SNY) Confirm Dupixent (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis June 19, 2020 7:32 AM - StreetInsider Dupixent® (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis June 19, 2020 7:30 AM - PR NewsWire Dupixent® (dupilumab) approved in China for adults with moderate-to-severe atopic dermatitis June 19, 2020 7:30 AM - StreetInsider Form SC 13D/A REGENERON PHARMACEUTICAL Filed by: Sanofi June 17, 2020 5:11 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jun 15 Filed by: Fenimore Christopher R. June 17, 2020 4:02 PM - SEC Filing Form 8-K REGENERON PHARMACEUTICAL For: Jun 12 June 16, 2020 4:33 PM - SEC Filing Form S-8 REGENERON PHARMACEUTICAL June 16, 2020 4:03 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jun 10 Filed by: Zoghbi Huda Y June 12, 2020 4:03 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jun 10 Filed by: Landry Robert E June 12, 2020 4:02 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jun 09 Filed by: Sanofi June 11, 2020 6:46 PM - SEC Filing Regeneron (REGN) Reports Two Science Publications Highlight Potential of REGN-COV2 Anti-Viral Antibody Cocktail to Protect Against SARS-CoV-2 Escape Mutants June 11, 2020 7:18 AM - StreetInsider Two Science Publications Highlight Potential of REGN-COV2 Anti-Viral Antibody Cocktail to Protect Against SARS-CoV-2 Escape Mutants June 11, 2020 7:17 AM - PR NewsWire Regeneron (REGN) announced initiation of first clinical trial of REGN-COV2, dual antibody cocktail for prevention and treatment of COVID-19 June 11, 2020 7:04 AM - StreetInsider Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19 June 11, 2020 7:00 AM - PR NewsWire Regeneron Collaborations on Dupixent® (dupilumab) Highlighted During Sanofi R&D Investor Event June 11, 2020 12:59 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: Jun 08 Filed by: Landry Robert E June 10, 2020 4:05 PM - SEC Filing Form SC 13G REGENERON PHARMACEUTICAL Filed by: FMR LLC June 10, 2020 10:14 AM - SEC Filing Regeneron Recognized as Healthcare Sector Leader on "The Civic 50" List of the Most Community-Minded Companies in the United States June 10, 2020 9:00 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: Jun 08 Filed by: GOLDSTEIN JOSEPH L June 9, 2020 4:05 PM - SEC Filing Regeneron Announces Virtual-Only Format for 2020 Annual Meeting of Shareholders June 8, 2020 9:00 AM - PR NewsWire Form DEFA14A REGENERON PHARMACEUTICAL June 8, 2020 8:48 AM - SEC Filing Regeneron (REGN) IV amid developing monoclonal antibodies intended to treat Covid-19 June 8, 2020 5:30 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Jun 05 Filed by: Bassler Bonnie L June 5, 2020 4:16 PM - SEC Filing Regeneron Announces Upcoming Investor Conference Presentations June 5, 2020 7:00 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: Jun 01 Filed by: RYAN ARTHUR F June 2, 2020 4:04 PM - SEC Filing Regeneron Pharma (REGN) PT Raised to $600 at BofA Securities June 2, 2020 10:03 AM - StreetInsider Regeneron Pharma (REGN) Reports Solid Clinical Progress at ASCO - Cowen June 2, 2020 7:57 AM - StreetInsider Regeneron Pharma (REGN) PT Jumps More than 50% to $624 at Cantor Fitzgerald June 2, 2020 6:58 AM - StreetInsider Regeneron Pharma (REGN) Update Points to COVID Clinical Testing in Coming Weeks - Jefferies June 2, 2020 6:22 AM - StreetInsider U.S. companies issue shares at fastest rate ever, selling the rally June 1, 2020 4:43 PM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: May 28 Filed by: SING GEORGE L June 1, 2020 4:09 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 28 Filed by: GOLDSTEIN JOSEPH L June 1, 2020 4:03 PM - SEC Filing Pre-Open Movers 06/01: (PTI) (COTY) (AAXN) Higher; (NVUS) (PFE) (GILD) Lower (more...) June 1, 2020 9:27 AM - StreetInsider Regeneron (REGN) and Intellia Therapeutics (NTLA) Expand Collaboration to Develop CRISPR/Cas9-Based Treatments June 1, 2020 7:04 AM - StreetInsider Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments June 1, 2020 7:00 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: May 29 Filed by: Sanofi May 29, 2020 4:18 PM - SEC Filing Form SC 13D/A REGENERON PHARMACEUTICAL Filed by: Sanofi May 29, 2020 4:17 PM - SEC Filing Form 8-K REGENERON PHARMACEUTICAL For: May 25 May 29, 2020 4:08 PM - SEC Filing Regeneron Completes Secondary Offering of Common Stock Held by Sanofi May 29, 2020 4:01 PM - PR NewsWire Sanofi announces closing of Regeneron stock sale May 29, 2020 4:01 PM - StreetInsider Regeneron (REGN) Announces Libtayo Longer-term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ASCO May 29, 2020 8:01 AM - StreetInsider Libtayo® (cemiplimab-rwlc) Longer-term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ASCO 2020 Show Durable Responses that Deepen Over Time May 29, 2020 8:00 AM - PR NewsWire Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time May 29, 2020 8:00 AM - StreetInsider Form 424B3 REGENERON PHARMACEUTICAL May 28, 2020 3:51 PM - SEC Filing Regeneron (REGN) Prices 11.8M Share Registered Direct Offering by Sanofi (SNY) at $515/Sh May 27, 2020 5:55 AM - StreetInsider Drugmaker Sanofi to raise over $11 billion via sale of Regeneron shares May 27, 2020 1:56 AM - StreetInsider Regeneron Announces Pricing of Secondary Offering of its Common Stock Held by Sanofi May 26, 2020 7:55 PM - PR NewsWire Sanofi announces pricing of Regeneron stock offering May 26, 2020 7:55 PM - StreetInsider Regeneron (REGN), Sanofi (SNY) Announce FDA Approves Dupixent as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis May 26, 2020 11:41 AM - StreetInsider Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis May 26, 2020 11:40 AM - StreetInsider FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis May 26, 2020 11:39 AM - PR NewsWire Pre-Open Stock Movers 05/26: (EVFM) (DFFN) (MARK) (NVAX) (NCLH) (CCL) (RCL) (more...) May 26, 2020 9:13 AM - StreetInsider Sanofi Could Turn Its Attention to BioMarin (BMRN) After Selling Regeneron Stake - RBC May 26, 2020 8:24 AM - StreetInsider Sanofi shares down despite $13 billion Regeneron payday May 26, 2020 7:54 AM - StreetInsider Wells Fargo Upgrades Regeneron Pharma (REGN) to Overweight May 26, 2020 6:36 AM - StreetInsider Form 424B3 REGENERON PHARMACEUTICAL May 26, 2020 6:17 AM - SEC Filing Form FWP REGENERON PHARMACEUTICAL Filed by: Sanofi May 26, 2020 6:12 AM - SEC Filing Form FWP REGENERON PHARMACEUTICAL Filed by: REGENERON PHARMACEUTICALS, INC. May 26, 2020 6:09 AM - SEC Filing Regeneron (REGN) Reports Dupixent (dupilumab) Eosinophilic Esophagitis Trial Meets Both Co-Primary Endpoints May 26, 2020 5:54 AM - StreetInsider UPDATE: Regeneron (REGN) Announces Proposed 12.8M Share Secondary by Sanofi (SNY) and $5B Share Buyback May 26, 2020 5:47 AM - StreetInsider Travel firms propel European stocks to strongest close in 11 weeks May 26, 2020 3:27 AM - StreetInsider Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration May 25, 2020 12:45 PM - StreetInsider Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock Repurchase May 25, 2020 12:40 PM - PR NewsWire Dupixent® (dupilumab) Eosinophilic Esophagitis Trial Meets Both Co-Primary Endpoints May 22, 2020 6:47 PM - PR NewsWire Dupixent® (dupilumab) eosinophilic esophagitis trial meets both co-primary endpoints May 22, 2020 6:25 PM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: May 20 Filed by: VAGELOS P ROY May 22, 2020 6:22 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 20 Filed by: VAGELOS P ROY May 22, 2020 6:22 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 14 Filed by: LAROSA JOSEPH J May 15, 2020 4:06 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 11 Filed by: SCHLEIFER LEONARD S May 13, 2020 9:01 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 11 Filed by: SING GEORGE L May 13, 2020 9:00 PM - SEC Filing Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio May 13, 2020 5:00 PM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: May 08 Filed by: STAHL NEIL May 11, 2020 4:41 PM - SEC Filing Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration May 11, 2020 7:00 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: May 06 Filed by: Van Plew Daniel P May 8, 2020 4:04 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 06 Filed by: Tessier-Lavigne Marc May 8, 2020 4:04 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 07 Filed by: Zoghbi Huda Y May 8, 2020 4:04 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 06 Filed by: RYAN ARTHUR F May 7, 2020 6:22 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 06 Filed by: BROWN MICHAEL S May 7, 2020 4:16 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: May 06 Filed by: GOLDSTEIN JOSEPH L May 6, 2020 4:20 PM - SEC Filing Regeneron Pharma (REGN) PT Raised to $555 at Morgan Stanley May 6, 2020 8:41 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $622 at SVB Leerink May 6, 2020 8:41 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $510 at Baird May 6, 2020 8:36 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $700 at Goldman Sachs May 6, 2020 6:44 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $525 at BMO Capital May 6, 2020 6:38 AM - StreetInsider Regeneron Pharma (REGN) PT Lowered to $524 at RBC Capital May 6, 2020 6:27 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $605 at Credit Suisse May 6, 2020 5:56 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $501 at JPMorgan, Following Earnings May 5, 2020 3:50 PM - StreetInsider Form 10-Q REGENERON PHARMACEUTICAL For: Mar 31 May 5, 2020 7:52 AM - SEC Filing Form 8-K REGENERON PHARMACEUTICAL For: May 05 May 5, 2020 7:35 AM - SEC Filing Wall Street rises as lockdowns ease, healthcare shares jump May 5, 2020 6:52 AM - StreetInsider Regeneron Pharma (REGN) ADVM Provides Gene Therapy Update - Jefferies May 5, 2020 6:34 AM - StreetInsider Regeneron (REGN) Tops Q1 EPS by 47c May 5, 2020 6:31 AM - StreetInsider Regeneron Reports First Quarter 2020 Financial and Operating Results May 5, 2020 6:30 AM - PR NewsWire Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma May 5, 2020 1:00 AM - StreetInsider Libtayo® (cemiplimab) Shows Clinically-Meaningful and Durable Responses in Second-line Advanced Basal Cell Carcinoma May 5, 2020 12:59 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: May 01 Filed by: RYAN ARTHUR F May 4, 2020 4:03 PM - SEC Filing Regeneron Announces Upcoming Investor Conference Presentations April 29, 2020 7:00 AM - PR NewsWire UPDATE: Citi Downgrades Regeneron Pharma (REGN) to Neutral April 28, 2020 4:47 AM - StreetInsider Sanofi: Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival April 27, 2020 9:24 AM - StreetInsider Regeneron (REGN) Reports Ph.3 Trial of Libtayo (cemiplimab) as Monotherapy for First-Line Advanced NSCLC Stopped Early Due to Highly Significant Improvement in OS April 27, 2020 7:01 AM - StreetInsider Phase 3 Trial of Libtayo® (cemiplimab) as Monotherapy for First-Line Advanced Non-small Cell Lung Cancer Stopped Early Due to Highly Significant Improvement in Overall Survival April 27, 2020 6:59 AM - PR NewsWire Regeneron (REGN), Sanofi (SNY) U.S. Phase 2/3 Adaptive-Designed Trial of Kevzara in Hospitalized COVID-19 Patients to Discontinue Lower-Dose, Continue Higher-Dose April 27, 2020 6:58 AM - StreetInsider Regeneron and Sanofi Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial of Kevzara® (sarilumab) in Hospitalized COVID-19 Patients April 27, 2020 6:58 AM - PR NewsWire Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients April 27, 2020 6:58 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $636 at Goldman Sachs April 27, 2020 6:33 AM - StreetInsider Investors bet on testing, treatments for restart of U.S. economy April 26, 2020 8:57 PM - StreetInsider Form DEFA14A REGENERON PHARMACEUTICAL April 24, 2020 4:18 PM - SEC Filing Form DEFA14A REGENERON PHARMACEUTICAL April 24, 2020 4:09 PM - SEC Filing Form DEF 14A REGENERON PHARMACEUTICAL For: Jun 12 April 24, 2020 4:08 PM - SEC Filing Regeneron Pharma (REGN) PT Raised to $596 at Credit Suisse April 21, 2020 6:23 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Apr 16 Filed by: Landry Robert E April 20, 2020 7:29 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Apr 16 Filed by: LAROSA JOSEPH J April 20, 2020 7:28 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Apr 16 Filed by: LAROSA JOSEPH J April 20, 2020 7:27 PM - SEC Filing Benchmark Upgrades Regeneron Pharma (REGN) to Buy April 17, 2020 6:19 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Apr 14 Filed by: LAROSA JOSEPH J April 16, 2020 4:04 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Apr 14 Filed by: Landry Robert E April 16, 2020 4:04 PM - SEC Filing Regeneron (REGN): We have moved our top SARS-CoV-2-neutralizing antibodies into preclinical- and clinical-scale cell production lines April 16, 2020 3:38 PM - StreetInsider Regeneron (REGN) Announces FDA Accepts for Priority Review BLA for REGN-EB3 to Treat Ebola April 16, 2020 7:01 AM - StreetInsider FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola April 16, 2020 7:00 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: Apr 13 Filed by: STAHL NEIL April 15, 2020 4:22 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Apr 09 Filed by: Landry Robert E April 13, 2020 7:24 PM - SEC Filing Regeneron (REGN) call put ratio 2.2 calls to 1 put amid Covid-19 April 13, 2020 5:03 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Apr 06 Filed by: Landry Robert E April 8, 2020 4:03 PM - SEC Filing Regeneron (REGN) 30-day option implied volatility at 56 compared to 52-week high of 78 April 8, 2020 2:03 PM - StreetInsider Benchmark Starts Regeneron Pharma (REGN) at Hold April 8, 2020 6:15 AM - StreetInsider Regeneron (REGN), Zai Lab Report Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) April 8, 2020 6:04 AM - StreetInsider Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) April 8, 2020 6:01 AM - StreetInsider Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) April 8, 2020 6:00 AM - Globe NewsWire Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) April 8, 2020 6:00 AM - PR NewsWire Wall Street volatility raises fears of another selloff April 7, 2020 5:51 PM - StreetInsider Investors await data on coronavirus drugs as market rally builds April 7, 2020 3:41 PM - StreetInsider Regeneron Pharma (REGN) PT Raised to $604 at SVB Leerink April 7, 2020 8:31 AM - StreetInsider Regeneron (REGN) Accounting Changes Will Result in Downward Adjustment - Morgan Stanley April 7, 2020 7:35 AM - StreetInsider Form 8-K REGENERON PHARMACEUTICAL For: Apr 05 April 7, 2020 6:46 AM - SEC Filing Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation April 6, 2020 5:00 PM - PR NewsWire Regeneron (REGN) option implied volatility decreases as shares up 2% April 6, 2020 10:59 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $435 at Wells Fargo April 6, 2020 6:15 AM - StreetInsider Regeneron (REGN) call put ratio 4.2 calls to 1 put amid wide price movement April 6, 2020 4:24 AM - StreetInsider Full Article List